Wilmington, Delaware, Feb. 20, 2025 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Non Vascular Stent Market by Product Type (Gastrointestinal Stents, Pulmonary Stents, Urological Stents, and Others), Material Type (Metallic Stents, and Non Metallic Stents), and End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “non vascular stent market” was valued at $1.6 billion in 2023, and is estimated to reach $2.7 billion by 2035, growing at a CAGR of 4.5% from 2024 to 2035.
Request Sample of the Report on Non Vascular Stent Market 2035 – https://www.alliedmarketresearch.com/request-sample/A324064
Prime determinants of growth
Rise in adoption of minimally invasive surgical procedures and presence of key players that drive the growth of the global non vascular stent market. However, regulatory compliance is anticipated to hinder the market growth. On the contrary, rise in technological advancements is expected to offer remunerative opportunities for the non vascular stent market during the forecast period.
Report coverage & details
| Report Coverage | Details |
| Forecast Period | 2024–2035 |
| Base Year | 2023 |
| Market Size in 2023 | $1.6 billion |
| Market Size in 2035 | $2.7 billion |
| CAGR | 4.5% |
| No. of Pages in Report | 285 |
| Segments covered | Product Type, Material Type, End User, and Region |
| Regional scope | North America, Europe, Asia-Pacific, LAMEA |
| Drivers |
|
| Opportunities |
|
| Restraints |
|
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A324064
The urological stents segment maintained its lead position during the forecast period.
Based on product type, the urological stents segment accounted for the largest share in 2023, accounting for more than one-third of the global non vascular stent market revenue. This dominance is attributed to rise in prevalence of urological disorders such as kidney stones, ureteral strictures, and benign prostatic hyperplasia (BPH). The increasing adoption of minimally invasive procedures, advancements in stent design improving biocompatibility and durability, and growing awareness among healthcare professionals further contributed to its market leadership.
The non metallic segment to maintain its lead position during the forecast period.
Based on material type, the non metallic segment accounted for the largest share in 2023, accounting for more than half of the global non vascular stent market revenue and is projected to register highest CAGR of 4.7% during the forecast period. This growth is attributed to rise in demand for biodegradable and polymer-based stents, which minimize long-term complications like inflammation and migration. Their ability to provide temporary support without requiring removal appeals to both patients and providers. Increased focus on patient-centric care, coupled with advancements in material technology and expanding applications, further accelerates the adoption of non-metallic stents.
The hospitals segment to maintain its lead position during the forecast period.
Based on end user, the hospitals segment accounted for the largest share in 2023, accounting for almost two-thirds of the global non vascular stent market revenue. This is attributed to their advanced infrastructure, specialized medical staff, and ability to perform complex procedures, including stent placement, with high precision. Hospitals offer a comprehensive range of services and are equipped with the latest technologies for diagnosing and treating conditions requiring non vascular stents. In addition, hospitals provide better access to post-procedure care and management, contributing to their dominance in the market.
North America to maintain its dominance by 2035
Based on region, North America held the highest market share in terms of revenue in 2023, accounting for almost two-fifths of the global non vascular stent market revenue. This is primarily attributed to its well-established healthcare infrastructure, advanced medical technology, and high healthcare expenditure. The presence of leading market players, favorable reimbursement policies, and rise in aging population contributed to the region’s dominance. In addition, North America’s strong research and development capabilities, along with high awareness on availability of non vascular stents and adoption of minimally invasive procedures, fueled the market growth.
For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/A324064
Leading Market Players
- Boston Scientific Corporation
- Becton, Dickinson, And Company
- W.L. Gore and Associate Inc.
- Micro-Tech (Nanjing) Co., Ltd.
The report provides a detailed analysis of these key players of the global nonvascular stent market. These players have adopted different strategy such product approval to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Get Customized Reports with your Requirements – https://www.alliedmarketresearch.com/request-for-customization/A324064
Trending Reports in Healthcare Industry:
Endoscopy Devices Market – Global Opportunity Analysis and Industry Forecast, 2024-2035
Prosthetic Heart Valve Market – Global Opportunity Analysis and Industry Forecast, 2024-2035
Vital Signs Monitoring Devices Market – Global Opportunity Analysis and Industry Forecast, 2024-2035
Single Cell Multiomics Market – Global Opportunity Analysis and Industry Forecast, 2024-2035
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
